SLC3A2
Amino acid transporter heavy chain SLC3A2
Also known as: 4F2, 4F2_HUMAN, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P08195
- Gene
- SLC3A2
- Ensembl
- ENSG00000168003
- Chromosome
- 11
- Canonical length
- 630 aa
- Protein class
- Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Plasma membrane
OverviewNCBI Gene
This gene is a member of the solute carrier family and encodes a cell surface, transmembrane protein. The protein exists as the heavy chain of a heterodimer, covalently bound through di-sulfide bonds to one of several possible light chains. The encoded transporter plays a role in regulation of intracellular calcium levels and transports L-type amino acids. Alternatively spliced transcript variants, encoding different isoforms, have been characterized. [provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
630 residues, UniProt reviewed canonical sequence.
>P08195|SLC3A2
1 MELQPPEASI AVVSIPRQLP GSHSEAGVQG LSAGDDSELG SHCVAQTGLE LLASGDPLPS
61 ASQNAEMIET GSDCVTQAGL QLLASSDPPA LASKNAEVTG TMSQDTEVDM KEVELNELEP
121 EKQPMNAASG AAMSLAGAEK NGLVKIKVAE DEAEAAAAAK FTGLSKEELL KVAGSPGWVR
181 TRWALLLLFW LGWLGMLAGA VVIIVRAPRC RELPAQKWWH TGALYRIGDL QAFQGHGAGN
241 LAGLKGRLDY LSSLKVKGLV LGPIHKNQKD DVAQTDLLQI DPNFGSKEDF DSLLQSAKKK
301 SIRVILDLTP NYRGENSWFS TQVDTVATKV KDALEFWLQA GVDGFQVRDI ENLKDASSFL
361 AEWQNITKGF SEDRLLIAGT NSSDLQQILS LLESNKDLLL TSSYLSDSGS TGEHTKSLVT
421 QYLNATGNRW CSWSLSQARL LTSFLPAQLL RLYQLMLFTL PGTPVFSYGD EIGLDAAALP
481 GQPMEAPVML WDESSFPDIP GAVSANMTVK GQSEDPGSLL SLFRRLSDQR SKERSLLHGD
541 FHAFSAGPGL FSYIRHWDQN ERFLVVLNFG DVGLSAGLQA SDLPASASLP AKADLLLSTQ
601 PGREEGSPLE LERLKLEPHE GLLLRFPYAALocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC3A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 178 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 178 nTPM
- kidney: 147 nTPM
- basal ganglia: 122 nTPM
- bone marrow: 115 nTPM
- skeletal muscle: 112 nTPM
- skin: 108 nTPM
Single-cell type
- syncytiotrophoblasts: 1,124 nCPM
- retinal pigment epithelial cells: 443 nCPM
- breast lactating cells: 401 nCPM
- migrating cytotrophoblasts: 289 nCPM
- basal keratinocytes: 284 nCPM
- esophageal basal cells: 273 nCPM
Immune cell
- plasmacytoid DC: 305 nTPM
- total PBMC: 186 nTPM
- MAIT T-cell: 158 nTPM
- classical monocyte: 149 nTPM
- intermediate monocyte: 148 nTPM
- non-classical monocyte: 124 nTPM
Brain region
- thalamus: 139 nTPM
- cerebellum: 105 nTPM
- medulla oblongata: 103 nTPM
- basal ganglia: 99 nTPM
- spinal cord: 98 nTPM
- pons: 93 nTPM
ReferencesPubMed · IEDB
Publications for SLC3A2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
3 publications
- Prospective study of lymphocyte subsets in subjects genetically susceptible to type 1 (insulin-dependent) diabetes.
1984 · Diabetologia · RCR 0.8 · 25 citations - Manipulation of CD98 resolves type 1 diabetes in nonobese diabetic mice.
2012 · J Immunol · RCR 0.2 · 8 citations - Quantitative immunological differences between newly diagnosed Graves' disease patients and relapsed patients.
1988 · J Endocrinol Invest · RCR 0.1 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.15
- DepMap mean gene effect
- -0.5
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- amino acid transport
- calcium ion transport
- carbohydrate metabolic process
- isoleucine transport
- L-alanine import across plasma membrane
- L-histidine transport
- L-leucine import across plasma membrane
- L-leucine transport
- methionine transport
- phenylalanine transport
- proline transport
- response to exogenous dsRNA
- symbiont entry into host cell
- thyroid hormone transport
- tryptophan transport
- tyrosine transport
- valine transport
Molecular functions
- aromatic amino acid transmembrane transporter activity
- cadherin binding
- double-stranded RNA binding
- exogenous protein binding
- L-alanine transmembrane transporter activity
- L-leucine transmembrane transporter activity
- neutral L-amino acid transmembrane transporter activity
- protein heterodimerization activity
- protein homodimerization activity
- RNA binding
- virus receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glycosyl hydrolase family 13, catalytic domain
- Glycosyl hydrolase, all-beta
- Glycoside hydrolase superfamily
- Alpha amylase, catalytic domain
- Solute carrier family 3 member 2, N-terminal domain
- Amino acid transporter heavy chain SLC3A2
- Solute carrier family 3 member 2 N-terminus
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC3A2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC3A2 as an antibody target. Whether an autoantibody or antibody against SLC3A2 could matter depends on whether native SLC3A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC3A2 is annotated at the cell surface, where native SLC3A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC3A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...